Sales & Marketing News | pharmaphorum

News

Novo Nordisk and Eli Lilly's GLP-1s offer big health benefits and are cost-effective at current US prices, but affordability remains an issue.

News

The FDA has set up a green list of overseas sources for GLP-1 ingredients to try to block imports of illegitimate and potentially unsafe materials.

News

The FDA's earlier decision to publish complete response letters was largely a repackaging of existing information, but now it has gone much further.

News

Telehealth startup Remedy Meds has expanded its position in the US market at a stroke with a $500m-plus deal to buy Thirty Madison.

News

This week saw both Gilead Sciences and Amgen start to fulfil pledges to step up capital investments in new US facilities.

News

Florida's plan to become the first US state to end all vaccine mandates, including children's pre-school shots, is labelled 'reckless'.